ReviewFrontiers in cardiovascular medicine2026
Clinical utility of lipoprotein(a) and the ApoB/ApoA-I ratio in the risk assessment of acute coronary syndrome: from single biomarkers to integrated risk stratification.
Zuqiang Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.